Welcome to our dedicated page for Trimas news (Ticker: TRS), a resource for investors and traders seeking the latest updates and insights on Trimas stock.
TriMas Corporation reports developments for a manufacturer and supplier serving consumer packaging, life sciences and industrial markets through TriMas Packaging and Specialty Products. Recurring updates cover operating results, earnings outlooks, quarterly dividends, share repurchases and portfolio actions, including the completed divestiture of TriMas Aerospace.
Company news also describes segment performance in closure and dispensing systems, specialty products such as cylinders, cost actions, restructuring benefits and conference-call communications tied to periodic earnings releases.
TriMas will host its fourth quarter and full year 2021 earnings conference call on March 1, 2022, at 10 a.m. Eastern Time, following the release of earnings results at 8 a.m.. Participation can be via dial-in at (888) 204-4368 (Code 9503603) or by accessing a live webcast on the TriMas website. A replay will be available from 3 p.m. EST on March 1 to 3 p.m. EST on March 8. TriMas operates in the packaging, aerospace, and specialty products markets, employing approximately 3,500 people across 12 countries.
Summary not available.
TriMas has successfully acquired Omega Plastics, enhancing its Packaging group by integrating Omega's custom components for medical and industrial applications. Omega's advanced injection molding and ISO Class 8 cleanroom capabilities will expedite product development and production. TriMas anticipates Omega to generate approximately $18 million in revenue in fiscal 2021, contributing to the Packaging group's total sales of around $534 million. This acquisition aims to bolster TriMas' offerings in medical device contract development manufacturing, propelling future growth opportunities.
TriMas (NASDAQ: TRS) announced its agreements to acquire Omega Plastics and TFI Aerospace, expanding its TriMas Packaging and TriMas Aerospace platforms. Omega, based in Clinton Township, Michigan, specializes in drug delivery and medical components, expected to generate $18 million in revenue for 2021. TFI, located near Toronto, Canada, produces specialty fasteners and anticipates $6 million in revenue. These acquisitions enhance TriMas's product offerings and innovation capabilities, while maintaining a net leverage ratio below 2.0x for further growth opportunities.
Summary not available.
Summary not available.
TriMas (TRS) reported strong financial results for Q3 2021, with net sales of $222.4 million, a 11.5% increase year-over-year. Operating profit surged to $30.8 million, compared to an operating loss in Q3 2020, largely due to prior impairment charges. Adjusted diluted EPS rose 9.6% to $0.57. The company initiated a dividend program, declaring $0.04 per share, enhancing its capital allocation strategy. TriMas also raised its 2021 Free Cash Flow outlook, predicting sales growth of 10% to 13% and adjusted EPS between $2.18 to $2.27, indicating a solid financial trajectory amidst ongoing macro uncertainties.
TriMas (NASDAQ: TRS) has announced a cash dividend of $0.04 per share, payable on November 10, 2021, to shareholders of record as of November 3, 2021. This marks the company's first dividend since its IPO in 2007. TriMas aims to regularly pay dividends, funded by its robust free cash flow. The company has recently focused on its Packaging segment, which now constitutes approximately 65% of its revenue. TriMas also plans to balance shareholder returns with investments in growth and acquisitions.
TriMas (NASDAQ: TRS) will host its third quarter 2021 earnings conference call on October 28, 2021, at 10 a.m. Eastern Time. The earnings results will be released earlier that day at 8 a.m.. Participants can join by calling (800) 367-2403 with the confirmation code 5060586 or via webcast at TriMas’ website. A replay will be available from October 28, 3 p.m. until November 4, 3 p.m. by dialing (888) 203-1112 (Replay Passcode 5060586).
Summary not available.